Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Early Oxidative Stress Biomarkers in Patients With Sepsis

NCT03802136 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT03802136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Early Oxidative Stress Biomarkers in Patients With Sepsis
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 30, 2018
Completion date
June 30, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aki, sepsis, sepsis, severe, septic shock